Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial. Messori A. Lancet 2024;404:338-339.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Messori A. Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial. Lancet 2024;404:338-339.
PMID: 39067900